Med-Tech Innovation November 28, 2023
1nhaler, a Scotland-based drug delivery device developer, has raised £2 million to develop its single-use dry powder inhaler (DPI).
Inhalable medicines are already widely used to treat conditions such as asthma, epilepsy, allergies and Parkinson’s but, to date, delivery options have been limited due to user accessibility, cost, performance and impact on the environment. 1nhaler has developed a way of enabling different dry powder drugs to be readily delivered in its device.
Other inhalers are typically made from bulky plastic and are expensive to manufacture and distribute. 1nhaler’s sustainable DPI is cardboard-based with the same dimensions as a credit card. The platform includes a breathable membrane which can be tailored to deliver individual drugs to patients.
Investment will allow...
Today's Sponsors
Today's Sponsor